CIK 0001680367 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 1.0 M | 1.7 M | 652000 | |
| Net income (USD) | -87.3 M | -101.9 M | -45.0 M | |
| Diluted EPS (USD/shares) | -0.7 | -2.05 | -2.41 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-11 | S-8 | S-8 | |
| 2026-08-11 | 8-K | 8-K items 2.02 | 2026-08-11 |
| 2026-08-11 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-17 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-07-07 | 4 | 4 | 2026-07-02 |
| 2026-07-02 | 4 | 4 | 2026-06-30 |
| 2026-07-02 | 4 | 4 | 2026-06-30 |
| 2026-07-02 | 144 | 144 | |
| 2026-07-01 | 144 | 144 | |
| 2026-06-30 | 144 | 144 | |
| 2026-06-17 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-15 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-11 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-11 | 4 | 4 | 2026-06-09 |
| 2026-06-11 | 8-K | 8-K items 1.01,9.01 | 2026-06-09 |
| 2026-06-11 | 424B5 | 424B5 | |
| 2026-06-09 | 4 | 4 | 2026-06-08 |
| 2026-06-09 | 4 | 4 | 2026-06-08 |
| 2026-06-09 | 424B5 | 424B5 | |
| 2026-06-09 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-06-08 |
| 2026-06-02 | 4 | 4 | 2026-05-29 |
| 2026-06-02 | 4 | 4 | 2026-05-29 |
Forms on file (last 1,000): 4 190, 8-K 48, 3 21, 10-Q 18, SC 13G/A 12, CORRESP 9, 144 8, UPLOAD 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=STTK (0.002 USD), /gw/filings/filings?ticker=STTK&form=8-K, /gw/filings/facts?ticker=STTK&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange